Literature DB >> 21628652

Francisella tularensis: a red-blooded pathogen.

J Wayne Conlan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21628652      PMCID： PMC3307161          DOI： 10.1093/infdis/jir224

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  18 in total

1.  Tularemia vaccine study. II. Respiratory challenge.

Authors:  S SASLAW; H T EIGELSBACH; J A PRIOR; H E WILSON; S CARHART
Journal:  Arch Intern Med       Date:  1961-05

2.  Tularemia vaccine study. I. Intracutaneous challenge.

Authors:  S SASLAW; H T EIGELSBACH; H E WILSON; J A PRIOR; S CARHART
Journal:  Arch Intern Med       Date:  1961-05

3.  AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS.

Authors:  F R McCrumb
Journal:  Bacteriol Rev       Date:  1961-09

4.  Proteomics analysis of the Francisella tularensis LVS response to iron restriction: induction of the F. tularensis pathogenicity island proteins IglABC.

Authors:  Juraj Lenco; Martin Hubálek; Pär Larsson; Alena Fucíková; Martin Brychta; Ales Macela; Jirí Stulík
Journal:  FEMS Microbiol Lett       Date:  2007-01-15       Impact factor: 2.742

5.  Identification of Francisella tularensis genes affected by iron limitation.

Authors:  Kaiping Deng; Robert J Blick; Wei Liu; Eric J Hansen
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Active suppression of the pulmonary immune response by Francisella tularensis Schu4.

Authors:  Catharine M Bosio; Helle Bielefeldt-Ohmann; John T Belisle
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

7.  Invasion of erythrocytes by Francisella tularensis.

Authors:  Joseph Horzempa; Dawn M O'Dee; Donna Beer Stolz; Jonathan M Franks; Doris Clay; Gerard J Nau
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

Review 8.  Nature of protective immunity to Francisella tularensis.

Authors:  A Tärnvik
Journal:  Rev Infect Dis       Date:  1989 May-Jun

Review 9.  Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options.

Authors:  G F Risi; D J Pombo
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

10.  Francisella tularensis has a significant extracellular phase in infected mice.

Authors:  Colin A Forestal; Meenakshi Malik; Sally V Catlett; Anne G Savitt; Jorge L Benach; Timothy J Sellati; Martha B Furie
Journal:  J Infect Dis       Date:  2007-05-23       Impact factor: 5.226
View more
  6 in total

Review 1.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

2.  Differing effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection.

Authors:  Dennis W Metzger; Sharon L Salmon; Girish Kirimanjeswara
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

3.  A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia.

Authors:  Charlotte A Hall; Helen C Flick-Smith; Sarah V Harding; Helen S Atkins; Richard W Titball
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

4.  The Sit-and-Wait Hypothesis in Bacterial Pathogens: A Theoretical Study of Durability and Virulence.

Authors:  Liang Wang; Zhanzhong Liu; Shiyun Dai; Jiawei Yan; Michael J Wise
Journal:  Front Microbiol       Date:  2017-11-03       Impact factor: 5.640

Review 5.  No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biol Rev Camb Philos Soc       Date:  2018-03-25

6.  Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.

Authors:  Jon Cuccui; Rebecca M Thomas; Madeleine G Moule; Riccardo V D'Elia; Thomas R Laws; Dominic C Mills; Diane Williamson; Timothy P Atkins; Joann L Prior; Brendan W Wren
Journal:  Open Biol       Date:  2013-05-22       Impact factor: 7.124
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.